NVDA gained a massive 197% since our AI first added it in November - is it time to sell? 🤔Read more

Syra Health wins $450,000 Shelby County health contract

EditorAhmed Abdulazez Abdulkadir
Published 27/02/2024, 13:50
© Reuters.
SYRA
-

CARMEL, Ind. - Syra Health Corp. (NASDAQ: SYRA), a healthcare technology company, has announced a new contract with the Shelby County Government in Tennessee to provide professional services to the Epidemiology Department of the Shelby County Health Department.

The one-year contract, valued at $450,000 with options to renew for two additional years, could reach a total value of $1.35 million.

The services to be provided by Syra Health include the assistance of senior epidemiologists and biostatisticians, aimed at enhancing the county's public health outcomes by improving epidemiological and advanced data analytics capabilities.

Dr. Deepika Vuppalanchi, CEO of Syra Health, emphasized the significance of the company's population health services and the opportunity this contract presents to improve public health in Shelby County.

Syra Health's involvement will focus on analyzing health data, identifying trends, and supporting evidence-based public health decisions. Dr. Srikant Devaraj, Vice President of Health Analytics and Population Health Business Unit Leader at Syra Health, reaffirmed the company's commitment to advancing population health through their collaboration with the Shelby County Health Department.

The contract expansion marks Tennessee as the 17th state where Syra Health is actively engaged, demonstrating the company's growing influence in the healthcare sector.

Syra Health specializes in addressing challenges in behavioral and mental health, digital health, and population health through innovative services and technology solutions. The company caters to a broad range of clients, including payers, providers, life sciences organizations, academic institutions, and government entities.

The information for this article is based on a press release statement.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.